Source - SMW
N+1 Singer today reaffirms its buy investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and cut its price target to 1350p (from 13500p).

Related Charts

Dechra Pharmaceuticals (DPH)

-6.50p (-0.46%)
delayed 10:12AM